Merit Medical Systems, Inc. (MMSI): Price and Financial Metrics

Merit Medical Systems, Inc. (MMSI)

Today's Latest Price: $58.11 USD

2.56 (4.61%)

Updated Dec 4 4:00pm

Add MMSI to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

MMSI Stock Summary

  • Merit Medical Systems Inc's stock had its IPO on February 26, 1992, making it an older stock than 81.8% of US equities in our set.
  • With a year-over-year growth in debt of -16.03%, Merit Medical Systems Inc's debt growth rate surpasses merely 17.64% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Merit Medical Systems Inc is reporting a growth rate of -168.51%; that's higher than only 11.66% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Merit Medical Systems Inc, a group of peers worth examining would be NVT, VG, ALOT, OPK, and ANIK.
  • Visit MMSI's SEC page to see the company's official filings. To visit the company's web site, go to

MMSI Stock Price Chart Interactive Chart >

Price chart for MMSI

MMSI Price/Volume Stats

Current price $58.11 52-week high $58.48
Prev. close $55.55 52-week low $25.18
Day low $55.76 Volume 425,100
Day high $58.48 Avg. volume 490,748
50-day MA $49.69 Dividend yield N/A
200-day MA $43.26 Market Cap 3.23B

Merit Medical Systems, Inc. (MMSI) Company Bio

Merit Medical Systems is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional and diagnostic procedures, particularly in cardiology, radiology and endoscopy. The company was founded in 1987 and is based in South Jordan, Utah.

MMSI Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$58.11$46.33 -16%

Below please find a table outlining a discounted cash flow forecast for MMSI, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Merit Medical Systems Inc ranked in the 44th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Merit Medical Systems Inc ended up being:

  • The company's compound free cash flow growth rate over the past 5.68 years comes in at 0.34%; that's greater than 71.27% of US stocks we're applying DCF forecasting to.
  • Merit Medical Systems Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -2.08. This coverage rate is greater than that of merely 17.54% of stocks we're observing for the purpose of forecasting via discounted cash flows.
  • The weighted average cost of capital for the company is 10. This value is greater than 78.43% stocks in the Healthcare sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as MMSI, try AMGN, IQV, INBP, LNTH, and USPH.

MMSI Latest News Stream

Event/Time News Detail
Loading, please wait...

MMSI Latest Social Stream

Loading social stream, please wait...

View Full MMSI Social Stream

Latest MMSI News From Around the Web

Below are the latest news stories about Merit Medical Systems Inc that investors may wish to consider to help them evaluate MMSI as an investment opportunity.

Outlook on the Global Femoral Closure Devices Market to 2024 - Featuring Abbott Vascular, Merit Medical & Rex Medical Among Others -

DUBLIN--(BUSINESS WIRE)--The "Global Femoral Closure Devices Market" report has been added to's offering. This report was developed using extensive primary and secondary research by the publisher's analysts. Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share f

Business Wire | September 28, 2020

The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-o...

Benzinga | September 9, 2020

Fed Circuit upholds sanctions on pro se doctors' 'frivolous assertions' in vascular patent case

A federal appeals court on Thursday upheld sanctions imposed on a father-and-son duo that unsuccessfully brought patent infringement claims against 300 defendants in the medical field, including device-maker Merit Medical Systems Inc, hospitals and individual physicians.

Reuters | August 13, 2020

Merit Medical (MMSI) Beats Q2 Earnings and Revenue Estimates

Merit Medical (MMSI) reported a drop in revenues at every key operating segment in Q2.

Yahoo | July 30, 2020

Merit Medical Systems Inc (MMSI) Q2 2020 Earnings Call Transcript

MMSI earnings call for the period ending June 30, 2020.

Yahoo | July 30, 2020

Read More 'MMSI' Stories Here

MMSI Price Returns

1-mo 13.81%
3-mo 18.50%
6-mo 28.39%
1-year 99.42%
3-year 34.36%
5-year 205.84%
YTD 86.13%
2019 -44.06%
2018 29.19%
2017 63.02%
2016 42.55%
2015 7.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.9606 seconds.